Targeted Therapies in Oncology
List Price:
$87.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Giuseppe Giaccone, Jean-Charles Soria
Format:
Paperback
Pages:
498
Publisher:
CRC Press (October 23, 2019)
Language:
English
Audience:
Professional and scholarly
ISBN-13:
9780367379360
Weight:
16oz
Dimensions:
6.125" x 9.1875"
File:
TAYLORFRANCIS-TayFran_260415045630016-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$87.99
Country of Origin:
United States
Pub Discount:
30
Case Pack:
1
As low as:
$83.59
Publisher Identifier:
P-CRC
Discount Code:
H
Imprint:
CRC Press
Overview
Major advances have been made in key pathways that control tumor progression. This has led to the development of new anticancer agents that can block the activity of proteins involved in neoplastic cell development and proliferation. This volume provides a concise panorama of existing targeted therapies and progress into future anticancer treatments. Topics include targeted agents of immune checkpoints, signal-transduction and stem cell inhibitors, antiangiogenic and vascular-disrupting agents, apoptosis modulators, and tumor profiling for drug development. The book emphasizes the biology behind this new class of drugs and the clinical achievements obtained.
